Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient AncestryJuliet N Barker, Christopher M Mazis, Sean M Devlin, et al.
Bone Marrow Transplantation|July 7, 2015
Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraAlberto Mussetti, Sean M Devlin, Hugo R Castro-Malaspina, et al.
Leukemia & Lymphoma|January 14, 2016
Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantationHeather Landau, Kevin Wood, David J Chung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2017
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic TransplantationBartlomiej M Getta, Sean M Devlin, Ross L Levine, et al.
Blood Advances|July 8, 2022
Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adultsIoannis Politikos, Carmen Lau, Sean M Devlin, et al.
Blood Advances|August 17, 2022
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantationMariam T Nawas, Miriam Sanchez-Escamilla, Sean M Devlin, et al.
Transplantation and Cellular Therapy|May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell TransplantationNatasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Blood|March 12, 2015
Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphomaCraig S Sauter, Matthew J Matasar, Jessica Meikle, et al.
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
Cancer Immunology Research|October 15, 2015
T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of ImmunotherapyDavid J Chung, Katherine B Pronschinske, Justin A Shyer, et al.
Pageof 22